ANEB·034569103·US·equity·Healthcare - Biotechnology-13D/G
ANEB (Anebulo Pharmaceuticals Inc) is held by 0 institutional investors as of Q1 2026. Net institutional sentiment: Bearish.
See how ANEB's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer